Apellis Pharmaceuticals I...
(APLS)
undefined
undefined%
At close: undefined
33.19
-0.15%
After-hours Dec 13, 2024, 04:15 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Cash & Equivalents | 351.19M | 551.80M | 640.19M | 565.78M | 351.99M | 176.27M | 175.64M | 24.86M | 36.00M | 13.62M | 4.76M |
| Short-Term Investments | 1.11M | 6.50M | 60.36M | 311.87M | - | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - | - | - | - | - | - |
| Other Long-Term Assets | 1.31M | 15.80M | 31.64M | 18.86M | 385.09K | 116.42K | 116.15K | 64.53K | 133.27K | 37.22K | - |
| Receivables | 206.44M | 7.73M | 10.10M | 25.00M | - | - | - | - | - | 465.85K | 67.22K |
| Inventory | 146.36M | 85.71M | 16.29M | 1.00 | - | - | - | - | - | 137.35K | 342.74K |
| Other Current Assets | 61.23M | 73.01M | 97.11M | 14.54M | 21.11M | 26.17M | 6.37M | 2.51M | 2.04M | 158.50K | 364.79K |
| Total Current Assets | 766.33M | 719.52M | 824.05M | 917.19M | 373.09M | 202.44M | 182.02M | 27.37M | 38.04M | 14.25M | 5.19M |
| Property-Plant & Equipment | 21.09M | 24.89M | 26.08M | 24.52M | 15.77M | 977.92K | - | - | - | 21.68K | 9.13K |
| Goodwill & Intangibles | - | - | - | - | - | - | - | - | - | - | - |
| Total Long-Term Assets | 22.40M | 40.69M | 57.72M | 43.38M | 16.15M | 1.09M | 116.15K | 64.53K | 133.27K | 58.90K | 9.13K |
| Total Assets | 788.73M | 760.22M | 881.76M | 960.57M | 389.24M | 203.53M | 182.13M | 27.43M | 38.18M | 14.31M | 5.20M |
| Account Payables | 37.52M | 37.34M | 16.91M | 8.48M | 8.36M | 10.25M | 3.66M | 2.55M | 2.48M | 751.53K | 353.87K |
| Deferred Revenue | - | - | 103.24M | 111.94M | - | - | - | - | - | - | - |
| Short-Term Debt | 6.44M | 5.63M | 4.12M | 3.69M | 5.22M | 1.67M | - | - | - | - | - |
| Other Current Liabilities | 203.64M | 124.64M | 110.82M | 116.17M | 52.17M | 5.10M | 2.89M | 1.09M | 722.73K | 330.00K | 323.09K |
| Total Current Liabilities | 247.59M | 167.61M | 131.85M | 128.33M | 65.75M | 17.02M | 6.55M | 3.64M | 3.20M | 1.08M | 676.96K |
| Long-Term Debt | 104.49M | 107.09M | 206.10M | 374.05M | 154.42M | 25.38M | 26.39M | - | - | - | - |
| Other Long-Term Liabilities | 242.13M | 315.65M | 345.15M | 253.64M | 134.84M | 158.78K | 244.29K | - | - | - | - |
| Total Long-Term Liabilities | 346.62M | 422.74M | 551.26M | 627.68M | 289.26M | 25.54M | 26.63M | - | - | - | - |
| Total Liabilities | 594.21M | 590.35M | 683.10M | 756.01M | 355.02M | 42.56M | 33.19M | 3.64M | 3.20M | 1.08M | 676.96K |
| Total Debt | 110.93M | 112.71M | 210.22M | 377.73M | 157.03M | 27.04M | 26.39M | - | - | - | - |
| Common Stock | 12.00K | 11.00K | 10.00K | 8.00K | 6.39K | 5.63K | 5.03K | 843.00 | 843.00 | 978.00 | 978.00 |
| Retained Earnings | -2.84B | -2.31B | -1.66B | -926.35M | -581.47M | -276.77M | -149.26M | -98.26M | -71.13M | -24.62M | -13.83M |
| Comprehensive Income | -3.54M | -875.00K | -2.09M | -117.00K | -153.78K | -122.81K | - | - | -0.00 | -21.51K | -15.61K |
| Shareholders Equity | 194.52M | 169.87M | 198.66M | 204.56M | 34.23M | 160.97M | 148.94M | 23.79M | 34.98M | 13.22M | 4.52M |
| Total Investments | 4.35M | 6.50M | 60.36M | 311.87M | - | - | - | - | - | - | - |